Predictors, indicators, and validated measures of dependence in menthol smokers

Journal of Addictive Diseases

Volumn 33, Issue 2, 2014, Pages 94-113

  Frost Pineda, Kimberly ^a   Muhammad Kah, Raheema ^a   Rimmer, Lonnie ^a   Liang, Qiwei ^a  

^a Altria Client Services Inc   (United States)

Author keywords

addiction; CPD; dependence; FTND; Menthol; smoking; TTFC

Indexed keywords

MENTHOL; NICOTINE;

ADULT; ARTICLE; HUMAN; SMOKING; STATISTICAL ANALYSIS; TOBACCO DEPENDENCE; WAKEFULNESS; AGED; BEHAVIOR, ADDICTIVE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; TOBACCO USE DISORDER; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BEHAVIOR, ADDICTIVE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTHOL; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SMOKING; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84903159402     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2014.909696     Document Type: Article

References (124)

1. Henningfield JE, Benowitz NL, Ahijevych K, Garrett BE, Connolly GN, Wayne GF. Does menthol enhance the addictiveness of cigarettes? An agenda for research. Nicotine Tob Res 2003; 5:9-11.
2. Tobacco Products Scientific Advisory Committee. Menthol cigarettes and public health: review of the scientific evidence andrecommendations.http://www. fda.gov/downloads/AdvisoryCommittees/Committees MeetingMaterials/TobaccoProducts Scientific AdvisoryCommittee/UCM269697.pdf (accessed May 13, 2014
3. Family Smoking Prevention and Tobacco Control Act. Section 907 of the Federal Food, Drug, and Cosmetic Act-Tobacco Product Standards. http://www.fda.gov/tobaccoproducts/guidancecompliancer egulatoryinformation/ ucm263053.htm (accessed May 8, 2014
4. Food and Drug Administration. Preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes. http://www.fda. gov/downloads/ScienceResearch/Special Topics/ PeerReviewofScientificInformation andAssessments/UCM361598.pdf (accessed May 13, 2014
5. Committee on the Development of the Third Edition of the Reference Manual on Scientific Evidence, Committee on Science TLC, Policy and Global Affairs (PGA), Federal Judicial Center, National Research Council. Reference manual on scientific evidence. 3rd ed. Washington, DC: The National Academies Press, 2011.
6. Roethig HJ, Munjal S, Feng S, et al. Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers. Nicotine Tob Res 2009; 11:1216-25.
7. Mendes P, Liang Q, Frost-Pineda K, Munjal S, Walk RA, Roethig HJ. The relationship between smoking machine derived tar yields and biomarkers of exposure in adult cigarette smokers in the US. Regul Toxicol Pharmacol 2009; 55:17-27.
8. Wang J, Roethig HJ, Appleton S, Werley M, Muhammad-Kah R, Mendes P. The effect of menthol containing cigarettes on adult smokers' exposure to nicotine and carbon monoxide. Regul Toxicol Pharmacol 2010; 57:24-30.
9. Frost-Pineda K, Liang Q, Liu J, et al. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res 2011; 13:182-93.
10. National Cancer Institute. Phenotypes and endophenotypes: foundations for genetic studies of nicotine use and dependence. Tobacco Control Monograph No. NIH Publication No. 09-6366.
11. Swan GE, Baker TB, Chassin L, Conti DV, Lerman C, Perkins KA, eds. Washington, DC: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 2009.
12. Hu MC, Davies M, Kandel DB. Epidemiology and correlates of daily smoking and nicotine dependence among young adults in the United States. Am J Public Health 2006; 96:299-308.
13. Breslau N, Fenn N, Peterson EL. Early smoking initiation and nicotine dependence in a cohort of young adults. Drug Alcohol Depend 1993; 33:129-37.
14. Breslau N, Peterson EL. Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences. Am J Public Health 1996; 86:214-20.
15. Chassin L, Presson CC, Pitts SC, Sherman SJ. The natural history of cigarette smoking from adolescence to adulthood in a midwestern community sample: multiple trajectories and their psychosocial correlates. Health Psychol 2000; 19: 223-31.
16. Riggs NR, Chou CP, Li C, Pentz MA. Adolescent to emerging adulthood smoking trajectories: when do smoking trajectories diverge, and do they predict early adulthood nicotine dependence? Nicotine Tob Res 2007; 9:1147-54.
17. Donny EC, Dierker LC. The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. Drug Alcohol Depend 2007; 89:93-6.
18. Kendler KS, Myers J, Damaj MI, Chen X. Early smoking onset and risk for subsequent nicotine dependence: a monozygotic co-twin control study. Am J Psychiatry 2013; 170:408-13.
19. U.S. Department of Health and Human Services. Preventing tobacco use among youth and young adults: a report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2012.
20. National Cancer Institute. Cancer Trends Progress Report-2011/2012 Update. Bethesda, MD: National Cancer Institute, NIH, DHHS, 2012.
21. Storr CL, Zhou H, Liang KY, Anthony JC. Empirically derived latent classes of tobacco dependence syndromes observed in recent-onset tobacco smokers: epidemiological evidence from a national probability sample survey. Nicotine Tob Res 2004; 6:533-45.
22. Khuder SA, Dayal HH, Mutgi AB. Age at smoking onset and its effect on smoking cessation. Addict Behav 1999; 24:673-7.
23. D'Avanzo B, La Vecchia C, Negri E. Age at starting smoking and number of cigarettes smoked. Ann Epidemiol 1994; 4:455-9.
24. Chen J, Millar WJ. Age of smoking initiation: implications for quitting. Health Rep 1998; 9:39-46.
25. Everett SA, Warren CW, Sharp D, Kann L, Husten CG, Crossett LS. Initiation of cigarette smoking and subsequent smoking behavior among U.S. high school students. Prev Med 1999; 29:327-33.
26. Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 1997; 6(Suppl 2): S57-S62.
27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, DSM-5. 5th ed. Arlington, VA: American Psychiatric Association, 2013.
28. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T. Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend 1994; 34:211-6.
29. Bover MT, Foulds J, Steinberg MB, Richardson D, Marcella SW. Waking at night to smoke as a marker for tobacco dependence: patient characteristics and relationship to treatment outcome. Int J Clin Pract 2008; 62:182-90.
30. Rice JP, Hartz SM, Agrawal A, et al. CHRNB3 is more strongly associated with Fagerström test for cigarette dependencebased nicotine dependence than cigarettes per day: phenotype definition changes genome-wide association studies results. Addiction 2012; 107:2019-28.
31. Agaku I, King B, Dube SR. Current cigarette smoking among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:889-94.
32. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: summary of national findings. HHS Publication No. (SMA) 12-4713. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2012.
33. Shiffman S, Dunbar MS, Scholl SM, Tindle HA. Smoking motives of daily and nondaily smokers: a profile analysis. Drug Alcohol Depend 2012; 126:362-8.
34. Shiffman S, Ferguson SG, Dunbar MS, Scholl SM. Tobacco dependence among intermittent smokers. Nicotine Tob Res 2012; 14:1372-81.
35. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100:299-303.
36. Baker RR, PiperM,McCarthyD, et al. Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res 2007; 9(Suppl 4):S555-S570.
37. Fu SS, Okuyemi KS, Partin MR, et al. Menthol cigarettes and smoking cessation during an aided quit attempt. Nicotine Tob Res 2008; 10:457-62.
38. U.S. Department of Health and Human Services. How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010.
39. Kandel DB, Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tob Res 2000; 2:263-74.
40. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Volume Methods for Evaluating Cancer Control Policies. Lyon, France: International Agency for Research on Cancer, 2008.
41. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86:1119-27.
42. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3:235-41.
43. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med 1989; 12:159-82.
44. Etter JF, Le Houezec J, Perneger TV. A selfadministered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. Neuropsychopharmacology 2003; 28:359-70.
45. Etter JF, Le Houezec J, Huguelet P, Etter M. Testing the Cigarette Dependence Scale in 4 samples of daily smokers: psychiatric clinics, smoking cessation clinics, a smoking cessation website and in the general population. Addict Behav 2009; 34: 446-50.
46. Okuyemi KS, Pulvers KM, Cox LS, et al. Nicotine dependence among African American light smokers: a comparison of three scales. Addict Behav 2007; 32:1989-2002.
47. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989; 84:791-800.
48. Shiffman S, Waters AJ, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res 2004; 6:327-48.
49. Shiffman S, Sayette MA. Validation of the nicotine dependence syndrome scale (NDSS): a criterion-group design contrasting chippers and regular smokers. Drug Alcohol Depend 2005; 79:45-52.
50. DiFranza JR, Savageau JA, Rigotti NA, et al. Trait anxiety and nicotine dependence in adolescents: a report from the DANDY study. Addict Behav 2004; 29:911-9.
51. Piper ME, Piasecki TM, Federman EB, et al. a multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol 2004; 72:139-54.
52. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association, 2000.
53. World Health Organization. International Statistical Classification of Diseases and Related Health Problems-10th revision. Geneva Switzerland: World Health Organization, 2010.
54. Lubin JH, Caporaso N, Hatsukami DK, Joseph AM, Hecht SS. The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics. Cancer Epidemiol Biomarkers Prev 2007; 16:1852-7.
55. Muscat JE, Chen G, Knipe A, Stellman SD, Lazarus P, Richie JP Jr. Effects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation. Cancer Epidemiol Biomarkers Prev 2009; 18:35-41.
56. Fagerström KO. Determinants of tobacco use and renaming the FTND to the Fagerström test for cigarette dependence. Nicotine Tob Res 2012; 14:75-8.
57. Allen B Jr., Unger JB. Sociocultural correlates of menthol cigarette smoking among adult African Americans in Los Angeles. Nicotine Tob Res 2007; 9:447-51.
58. Faseru B, Choi WS, Krebill R, et al. Factors associated with smoking menthol cigarettes among treatment-seeking African American light smokers. Addict Behav 2011; 36:1321-4.
59. Gandhi KK, Foulds J, Steinberg MB, Lu SE, Williams JM. Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract 2009; 63:360-7.
60. Hymowitz N, Corle D, Royce J, et al. Smokers' baseline characteristics in the COMMIT trial. PrevMed 1995; 24:503-8.
61. Okuyemi KS, Ebersole-Robinson M, Nazir N, Ahluwalia JS. African-American menthol and nonmenthol smokers: differences in smoking and cessation experiences. J Natl Med Assoc 2004; 96:1208-11.
62. Pletcher MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arch Intern Med 2006; 166:1915-22.
63. Rosenbloom J, Rees VW, Reid K, Wong J, Kinnunen T. A cross-sectional study on tobacco use and dependence among women: does menthol matter? Tob Induc Dis 2012; 10:19.
64. Jones MR, Apelberg BJ, Tellez-Plaza M, Samet JM, Navas-Acien A. Menthol cigarettes, race/ethnicity, and biomarkers of tobacco use in U.S. adults: the 1999-2010 National Health and Nutrition Examination Survey (NHANES). Cancer Epidemiol Biomarkers Prev 2013; 22:224-32.
65. Jain RB. Trends in serum cotinine concentrations among daily cigarette smokers: data from NHANES 1999-2010. Sci Total Environ 2014; 472:72-7.
66. Cubbin C, Soobader MJ, LeClere FB. The intersection of gender and race/ethnicity in smoking behaviors among menthol and non-menthol smokers in the United States. Addiction 2010; 105(Suppl 1): 32-8.
67. Hyland A, Garten S, Giovino GA, Cummings KM. Mentholated cigarettes and smoking cessation: findings from COMMIT. Tob Control 2002; 11:135-9.
68. Lawrence D, Rose A, Fagan P, Moolchan ET, Gibson JT, Backinger CL. National patterns and correlates of mentholated cigarette use in the United States. Addiction 2010; 105(Suppl 1):13-31.
69. Okuyemi KS, Faseru B, Sanderson Cox L, Bronars CA, Ahluwalia JS. Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction 2007; 102:1979-86.
70. Stahre M, Okuyemi KS, Joseph AM, Fu SS. Racial/ethnic differences in menthol cigarette smoking, population quit ratios and utilization of evidence-based tobacco cessation treatments. Addiction 2010; 105 (Suppl 1):75-83.
71. Fagan P, Moolchan ET, Hart A Jr., Rose A, Lawrence D, Shavers VL, Gibson JT. Nicotine dependence and quitting behaviors among menthol and non-menthol smokers with similar consumptive patterns. Addiction 2010; 105(Suppl 1):55-74.
72. Fernander A, Rayens MK, Zhang M, Adkins S. Are age of smoking initiation and purchasing patterns associated with menthol smoking? Addiction 2010; 105 (Suppl 1):39-45.
73. Alexander LA, Crawford T, Mendiondo MS. Occupational status, work-site cessation programs and policies and menthol smoking on quitting behaviors of US smokers. Addiction 2010; 105(Suppl 1):95-104.
74. Marsh L, McGee R, Gray A. A refreshing poison: one-quarter of young New Zealand smokers choose menthol. Aust New Zealand J Public Health 2012; 36:495-6.
75. Li J, Paynter J, Arroll B. A cross-sectional study of menthol cigarette preference by 14-to 15-year-old smokers in New Zealand. Nicotine Tob Res 2012; 14:857-63.
76. Giovino GA, Villanti AC, Mowery PD, et al. Differential trends in cigarette smoking in the USA: Is menthol slowing progress? Tob Control. [Epub ahead of print September 27, 2013].
77. Muilenburg JL, Legge JS Jr. African American adolescents and menthol cigarettes: smoking behavior among secondary school students. J Adolesc Health 2008; 43:570-5.
78. Ahijevych K, Ford J. The relationships between menthol cigarette preference and state tobacco control policies on smoking behaviors of young adult smokers in the 2006-07 Tobacco Use Supplements to the Current Population Surveys (TUS CPS). Addiction 2010; 105(Suppl 1):46-54.
79. Mendiondo MS, Alexander LA, Crawford T. Health profile differences for menthol and non-menthol smokers: findings from the National Health Interview Survey. Addiction 2010; 105(Suppl 1):124-40.
80. Rostron B. NNAL exposure by race and menthol cigarette use among U.S. smokers. Nicotine Tob Res 2013; 15:950-6.
81. Murray RP, Connett JE, Skeans MA, Tashkin DP. Menthol cigarettes and health risks in Lung Health Study data. Nicotine Tob Res 2007; 9:101-7.
82. Okuyemi KS, Ahluwalia JS, Ebersole-Robinson M, Catley D, Mayo MS, Resnicow K. Does menthol attenuate the effect of bupropion among African American smokers? Addiction 2003; 98:1387-93.
83. Collins CC, Moolchan ET. Shorter time to first cigarette of the day in menthol adolescent cigarette smokers. Addict Behav 2006; 31:1460-4.
84. Winhusen TM, Adinoff B, Lewis DF, et al. A tale of two stimulants: Mentholated mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence. Drug Alcohol Depend 2013; 133:845-51.
85. Rojewski AM, Toll BA, O'Malley SS. Menthol cigarette use predicts treatment outcomes of weight-concerned smokers. Nicotine Tob Res 2014; 16:115-9.
86. Blot WJ, Cohen SS, Aldrich M, McLaughlin JK, Hargreaves MK, Signorello LB. Lung cancer risk among smokers of menthol cigarettes. J Natl Cancer Inst 2011; 103:810-6.
87. Muscat JE, Richie JP Jr., Stellman SD. Mentholated cigarettes and smoking habits in whites and blacks. Tob Control 2002; 11:368-71.
88. Sidney S, Tekawa IS, Friedman GD, Sadler MC, Tashkin DP. Mentholated cigarette use and lung cancer. Arch Intern Med 1995; 155:727-32.
89. Mustonen TK, Spencer SM, Hoskinson RA, Sachs DP, Garvey AJ. The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine Tob Res 2005; 7:581-90.
90. Brooks DR, Palmer JR, Strom BL, Rosenberg L. Menthol cigarettes and risk of lung cancer. AmJ Epidemiol 2003; 158:609-16.
91. Jones MR, Apelberg BJ, Samet JM, Navas-Acien A. Smoking, menthol cigarettes, and peripheral artery disease in U.S. adults. Nicotine Tob Res 2013; 15:1183-9.
92. Rostron B. Lung cancer mortality risk for U.S. menthol cigarette smokers. Nicotine Tob Res 2012; 14:1140-4.
93. Luo Z, Alvarado GF, Hatsukami DK, Johnson EO, Bierut LJ, Breslau N. Race differences in nicotine dependence in the Collaborative Genetic study of Nicotine Dependence (COGEND). Nicotine Tob Res 2008;10:1223-30.
94. Hickman NJ 3rd, Delucchi KL, Prochaska JJ. Menthol use among smokers with psychological distress: findings from the 2008 and 2009 National Survey on Drug Use and Health. Tob Control. 2014; 23:7-13.
95. Ahijevych K, Parsley LA. Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addict Behav 1999; 24:115-20.
96. Benowitz NL, Dains KM, Dempsey D, Havel C, Wilson M, Jacob P 3rd. Urine menthol as a biomarker of mentholated cigarette smoking. Cancer Epidemiol Biomarkers Prev 2010; 19:3013-9.
97. D'Silva J, Boyle RG, Lien R, Rode P, Okuyemi KS. Cessation outcomes among treatment-seeking menthol and nonmenthol smokers. Am J Prev Med 2012; 43(5 Suppl 3):S242-S248.
98. Muscat JE, Liu HP, Stellman SD, Richie JP Jr. Menthol smoking in relation to time to first cigarette and cotinine: results from a community-based study. Regul Toxicol Pharmacol 2012; 63:166-70.
99. Reitzel LR, Etzel CJ, Cao Y, Okuyemi KS, Ahluwalia JS. Associations of menthol use with motivation and confidence to quit smoking. Am J Health Behav 2013; 37:629-34.
100. Jones MR, Tellez-Plaza M, Navas-Acien A. Smoking, menthol cigarettes and all-cause, cancer and cardiovascular mortality: evidence from the National Health and Nutrition Examination Survey (NHANES) and a meta-analysis. PLoS One 2013; 8:e77941.
101. Moolchan ET, Berlin I, Robinson ML, Cadet JL. African-American teen smokers: Issues to consider for cessation treatment. J Natl Med Assoc 2000; 92:558-62.
102. Duncan AE, Lessov-Schlaggar CN, Sartor CE, Bucholz KK. Differences in time to onset of smoking and nicotine dependence by race/ethnicity in a Midwestern sample of adolescents and young adults from a high risk family study. Drug Alcohol Depend 2012; 125: 140-5.
103. DiFranza JR, Savageau JA, Fletcher K, et al. Recollections and repercussions of the first inhaled cigarette. Addict Behav 2004; 29:261-72.
104. Hooper MW, Zhao W, Byrne MM, et al. Menthol cigarette smoking and health, Florida 2007 BRFSS. Am J Health Behav 2011; 35:3-14.
105. Reitzel LR, Li Y, Stewart DW, et al. Race moderates the effect of menthol cigarette use on short-term smoking abstinence. Nicotine Tob Res 2013; 15:883-9.
106. Brody AL, Mukhin AG, La Charite J, et al. Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers. Int J Neuropsychopharmacol 2013; 16:957-66.
107. Zedler BK, Kinser R, Oey J, et al. Biomarkers of exposure and potential harm in adult smokers of 3-7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers. Biomarkers 2006; 11:201-20.
108. World Medical Association, 2000
109. Wackowski OA, Delnevo CD. Menthol cigarettes and indicators of tobacco dependence among adolescents. Addict Behav 2007; 32:1964-9.
110. Hersey JC, Ng SW, Nonnemaker JM, et al. Are menthol cigarettes a starter product for youth? Nicotine Tob Res 2006; 8:403-13.
111. Hersey JC, Nonnemaker JM, Homsi G. Menthol cigarettes contribute to the appeal and addiction potential of smoking for youth. Nicotine Tob Res 2010; 12 (Suppl 2):S136-S146.
112. Nonnemaker J, Hersey J, Homsi G, Busey A, Allen J, Vallone D. Initiation with menthol cigarettes and youth smoking uptake. Addiction 2013; 108:171-8.
113. Reitzel LR. Menthol cigarettes, tobacco dependence, and smoking cessation: Project MOM final report. U.S. Food and Drug Administration commissioned secondary analysis. 2010. http://www.fda.gov/downloavds/ AdvisoryCommittees/Committees-MeetingMaterials/ TobaccoProductsScientificAdvisoryCommittee/UCM237558.pdf (accessed May 13, 2014
114. Reitzel LR. Menthol cigarettes, tobacco dependence, and smoking cessation: Project CARE final report. U.S. Food and Drug Administration commissioned secondary analysis. 2010. http://www.fda.gov/downloads/ AdvisoryCommittees/Committees MeetingMaterials/ TobaccoProductsScientificAdvisoryCommittee/UCM237557.pdf (accessed May 13, 2014
115. Reitzel LR. Menthol cigarettes, tobacco dependence, and smoking cessation: Project BREAK FREE final report. U.S. Food and Drug Administration commissioned secondary analysis. 2010. http://www.fda. gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Tobacco ProductsScientificAdvisoryCommittee/UCM237556.pdf (accessed May 13, 2014
116. Reitzel LR, Nguyen N, Cao Y, et al. Race/ethnicity moderates the effect of prepartum menthol cigarette use on postpartum smoking abstinence. Nicotine Tob Res 2011; 13:1305-10.
117. National Cancer Institute. Menthol cigarette use among current smokers ages 18 C years by socio-demographic characteristics, Tobacco Use Supplement to the Current Population Survey, 2006/2013. http://cancercontrol.cancer. gov/tcrb/research-topic-menthol.html (accessed May 13, 2014
118. Gardiner PS. The African Americanization of menthol cigarette use in the United States. Nicotine Tob Res 2004; 6(Suppl 1):S55-S65.
119. Unger JB, Allen B Jr., Leonard E, Wenten M, Cruz TB. Menthol and non-menthol cigarette use among Black smokers in Southern California. Nicotine Tob Res 2010; 12:398-407.
120. Cropsey KL, Weaver MF, Eldridge GD, Villalobos GC, Best AM, Stitzer MI. Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob Res 2009; 11:690-7.
121. Faseru B, Nollen NL, Mayo MS, et al. Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial. Addict Behav 2013; 38: 1796-803.
122. Foulds J, Gandhi KK, Steinberg MB, et al. Factors associated with quitting smoking at a tobacco dependence treatment clinic. Am J Health Behav 2006; 30:400-12.
123. Harris KJ, Okuyemi KS, Catley D, Mayo MS, Ge B, Ahluwalia JS. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. Prev Med 2004; 38:498-502.
124. Steinberg MB, Delnevo CD, Hrywna M. Update in New Jersey tobacco-dependence treatment. N J Med 2002; 99 (11):21-6.